CD44 variant isoforms on blood leukocytes in chronic inflammatory bowel disease and other systemic autoimmune diseases

Laboratory Investigation

Volumn 79, Issue 6, 1999, Pages 747-759

  Wittig, Bianca ^a   Seiter, Simone ^b   Schmidt, Dirk Steffen ^a   Zuber, Margit ^b   Neurath, Markus ^c   Zöller, Margot ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD44V ANTIGEN; HERMES ANTIGEN; MONOCLONAL ANTIBODY;

ADULT; ANTIBODY SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; CELL ACTIVATION; CELL PROLIFERATION; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENTEROCOLITIS; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKOCYTE; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL;

ADULT; AGED; ANIMALS; ANTIGENS, CD; ANTIGENS, CD44; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATORY BOWEL DISEASES; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MALE; MICE; MIDDLE AGED; MONOCYTES; PROTEIN ISOFORMS; REFERENCE VALUES; VARIATION (GENETICS);

EID: 0033020640     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (77)

1. Andrews JM, Norton I, Dent O, and Goulston K (1995). Inflammatory bowel disease: A retrospective review of a specialist-based cohort. Med J Aust 163:133-136.
2. Arch R, Wirth K, Hofmann M, Ponta H, Matzku S, Herrlich P, and Zöller M (1992). Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science 257:682-685.
3. Archelos JJ and Hartung HP (1997). The role of adhesion molecules in multiple sclerosis: Biology, pathogenesis and therapeutic implications. Mol Med Today 3:310-321.
4. Bhatti MA and Hodgson HJ (1995). Animal models of inflammatory bowel disease. Int J Exp Pathol 76:309-315.
5. Bourguignon LY, Lokeshwar VB, Chen X, and Kerrick WG (1993). Hyaluronic acid-induced lymphocyte signal transduction and HA receptor (GP85/CD44) cytoskeleton interaction. J Immunol 151:6634-6644.
6. Bowling E (1995). Inflammatory bowel disease. Eur J Gastroenterol Hepatol 7:521-527.
7. Burdin N, Rousset F, and Banchereau J (1997). B-cell-derived IL-10: Production and function. Methods 11:98-111.
8. Calcinaro F, Gambelunghe G, and Lafferty KJ (1997). Protection from autoimmune diabetes by adjuvant therapy in the non-obese diabetic mouse: The role of interleukin-4 and interleukin-10. Immunol Cell Biol 75:467-471.
9. Chu EB, Hobbs MV, Wilson CB, Romball CG, Linsley PS, and Weigle WO (1996). Intervention of CD4+ cell subset shifts and autoimmunity in the BXSB mouse by murine CTLA4lg. J Immunol 156:1262-1268.
10. Datta SK and Kalled SL (1997). CD40-CD40 ligand interaction in autoimmune disease. Arthritis Rheum 40:1735-1745.
11. Dieleman LA, Pena AS, Meuwissen SG, and van Rees EP (1997). Role of animal models for the pathogenesis and treatment of inflammatory bowel disease. Scand J Gastroenterol Suppl 223:99-104.
12. Elson CO, Beagley KW, Sharmanov AT, Fujihashi K, Kiyono H, Tennyson GS, Cong Y, Black CA, Ridwan BW, and McGhee JR (1996). Hapten-induced model of murine inflammatory bowel disease: Mucosa immune responses and protection by tolerance. J Immunol 157:2174-2185.
13. Elson CO, Sartor RB, Tennyson GS, and Riddell RH (1995). Experimental models of inflammatory bowel disease. Gastroenterology 109:1344-1367.
14. Finck BK, Linsley PS, and Wofsy D (1994). Treatment of murine lupus with CTLA4lg. Science 265:1225-1227.
15. Fitch FW, McKisic MD, Lancki DW, and Gajewski TF (1993). Differential regulation of murine T lymphocyte subsets. Annu Rev Immunol 11:29-48.
16. Gallon L, Chandraker A, Isazadeh S, Peach R, Linsley PS, Turka LA, Sayegh MH, and Khoury SJ (1997). Differential effects of B7-1 blockade in the rat experimental autoimmune encephalomyelitis model. J Immunol 159:4212-4216.
17. Galluzzo E, Albi N, Fiorucci S, Merigiola C, Ruggeri L, Tosti A, Grossi CE, and Velardi A (1995). Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells. Eur J Immunol 25:2932-2939.
18. Garrone P, Neidhardt EM, Garcia E, Galibert L, van Kooten C, and Banchereau J (1995). Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J Exp Med 182: 1265-1273.
19. Quo YJ, Lin SC, Wang JH, Bigby M, and Sy MS (1994). Palmitoylation of CD44 interferes with CDS mediated signaling in human T lymphocytes. Int Immunol 6:213-221.
20. Quo Y, Wu Y, Shinde S, Sy MS, Aruffo A, and Liu Y (1996). Identification of a costimulatory molecule rapidly induced by CD40L as CD44H. J Exp Med 184:955-961.
21. Heider KH, Hofmann M, Horst E, van den Berg F, Ponta H, Herrlich P, and Pals ST (1993). A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J Cell Biol 120:227-233.
22. Herrlich P, Zöller M, Pals ST, and Ponta H (1993). CD44 splice variants: Metastases meet lymphocytes. Immunol Today 14:395-399.
23. Hodgson HJ (1997). New therapeutic approaches in inflammatory bowel disease. Neth J Med 50:15-18.
24. Kavanaugh A (1996). Adhesion molecules as therapeutic targets in the treatment of allergic and immunologically mediated diseases. Clin Immunol Immunopathol 80:15-22.
25. Kelleher D, Murphy A, Feighery C, and Casey EB (1995). Leukocyte function-associated antigen 1 (LFA-1) and CD44 are signalling molecules for cytoskeleton-dependent morphological changes in activated T cells. J Leukoc Biol 58: 539-546.
26. Kelsall BL, Stuber E, Neurath M, and Strober W (1996). Interleukin-12 production by dendritic cells: The role of Cd40-CD40L interaction in TH1 T-cell responses. Ann NY Acad Sci 795:116-126.
27. Kim HS and Berstad A (1992). Experimental colitis in animal models. Scand J Gastroenterol 27:529-537.
28. Kluth DC and Rees AJ (1996). Inhibiting inflammatory cytokines. Semin Nephrol 16:576-582.
29. Kojouharoff G, Hans W, Obermeier F, Mannel DN, Andus T, Scholmerich J, Gross V, and Falk W (1997). Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice. Clin Exp Immunol 107:353-358.
30. Koopman G, Heider KH, Horst E, Adolf GR, van den Berg F, Ponta H, Herrlich P, and Pals ST (1993). Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med 177:897-904.
31. Koshy M, Berger D, and Crow MK (1996). Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. J Clin Invest 98:826-837.
32. Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, Weiner HL, Nabavi N, and Glimcher LH (1995). B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy. Cell 80:707-718.
33. Kuhn R, Lohler J, Rennick D, Rajewsky K, and Muller W (1993). Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75:263-274.
34. Levesque MC and Haynes BF (1996). In vitro culture of human peripheral blood monocytes induces hyaluronan binding and up-regulates monocyte variant CD44 isoform expression. J Immunol 156:1557-1565.
35. Lofberg R (1997). Medical treatment for inflammatory bowel disease: Refinements and new modalities. J Int Med 241: 1-4.
36. Lucey DR, Clerici M, and Shearer GM (1996). Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin Microbiol Rev 9:532-562.
37. MacDonald TT (1994). Gastrointestinal inflammation: Inflammatory bowel disease in knockout mice. Curr Biol 4:261-263.
38. Maltzman JS, Carmen JA, and Monroe JG (1996). Transcriptional regulation of the ICAM-1 gene in antigen receptor- and phorbol ester-stimulated B lymphocytes: Role for transcription factor EGR1. J Exp Med 183:1747-1759.
39. Meenan J, Hommes DW, Mevissen M, Dijkhuizen S, Soule H, Moyle M, Buller HR, ten Kate FW, Tytgat GN, and van Deventer SJ (1996). Attenuation of the inflammatory response in an animal colitis model by neutrophil inhibitory factor, a novel beta 2-integrin antagonist. Scand J Gastroenterol 31:786-791.
40. Mombaerts P, Mizoguchi E, Grusby MJ, Glimcher LH, Bhan AK, and Tonegawa S (1993). Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 75:274-282.
41. Moreland LW, Heck Jr LW, Sullivan W, Pratt PW, and Koopman WJ (1993). New approaches to the therapy of autoimmune diseases: Rheumatoid arthritis as a paradigm. Am J Med Sci 305:40-51.
42. Mosmann TR and Moore KW (1991). The role of IL-10 in crossregulation of TH1 and TH2 responses. Immunol Today 12:49-53.
43. Narula SK, Cutler D, and Grint P (1998). Immunomodulation of Crohn's disease by interleukin 10. Agents Actions 49(Suppl):57-65.
44. Neurath MF, Fuss I, Kelsall BL, Presky DH, Waegell W, and Strober W (1996a). Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance. J Exp Med 183:2605-2616.
45. Neurath MF, Fuss I, Kelsall BL, Stuber E, and Strober W (1995). Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med 182:1281-1290.
46. Neurath MF, Petterson S, Meyer zum Buschenfelde KH, and Strober W (1996b). Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat Med 2:998-1004.
47. Ni J, Chen FS and Hollander D (1996). Immunological abnormality in C3H/He mice with heritable inflammatory bowel disease. Cell Immunol 169:7-15.
48. Podolsky DK (1997). Lessons from genetic models of inflammatory bowel disease. Acta Gastroenterol Belg 60:163-165.
49. Powrie F, Carlino J, Leach MW, Mauze S, and Coffman RL (1996). A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells. J Exp Med 183:2669-2674.
50. Powrie F and Leach MW (1995). Genetic and spontaneous models of inflammatory bowel disease in rodents: Evidence for abnormalities in mucosal immune regulation. Ther Immunol 2:115-123.
51. Rothman BL, Blue ML, Kelley KA, Wunderlich D, Mierz DV, and Aune TM (1991). Human T cell activation by OKT3 is inhibited by a monoclonal antibody to CD44. J Immunol 147:2493-2499.
52. Rudolph U, Finegold MJ, Rich SS, Harriman GR, Srinivasan Y, Brabet P, Bradley A, and Birnbaumer L (1995). Gi2 alpha protein deficiency: A model of inflammatory bowel disease. J Clin Immunol 15(Suppl 6):101S-105S.
53. Ruuls SR and Sedgwick JD (1998). Cytokine-directed therapies in multiple sclerosis and experimental autoimmune encephalomyelitis. Immunol Cell Biol 76:65-73.
54. Samoilova EB, Horton JL, Zhang H, and Chen Y (1997). CD40L blockade prevents autoimmune encephalomyelitis and hampers TH1 but not TH2 pathway of T cell differentiation. J Mol Med 75:603-608.
55. Schattner EJ, Elkon KB, Yoo DH, Tumang J, Krammer PH, Crow MK, and Friedman SM (1995). CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. J Exp Med 182:1557-1565.
56. Sedlack B, Merz H, Schorle H, Schimpl A, Feller AC, and Horak I (1993). Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75:253-261.
57. Seiter S, Schadendorf D, Tilgen W, and Zöller M (1998). CD44 variant isoform expression in autoimmune infiltration of the skin. Clin Immunol Immunopathol 89:79-93.
58. Shanahian F (1994). Gene-targeted immunological knockouts: New models of inflammatory bowel disease. Gastroenterology 107:312-314.
59. Shaw MK, Lorens B, Dhawan A, DalCanto R, Tse HY, Tran AB, Bonpane C, Eswaran SL, Brocke S, Sarvetnick N, Steinman L, Nolan GP, and Fathman CG (1997). Local delivery of IL-4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis. J Exp Med 185:1711-1714.
60. Shimizu Y, Van Seventer GA, Siraganian R, Wahl L, and Shaw S (1989). Dual role of the CD44 molecule in T cell adhesion and activation. J Immunol 143:2457-2463.
61. Steinman L (1995). Escape from "horror autotoxicus": Pathogenesis and treatment of autoimmune disease. Cell 80:7-10.
62. Strober W, Kelsall B, Fuss I, Marth T, Ludviksson B, Ehrhardt R, and Neurath M (1997). Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation. Immunol Today 18:61-64.
63. Stuber E, Strober W, and Neurath M (1996). Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J Exp Med 183:693-698.
64. Su X, Zhou T, Yang P, Edwards CK, and Mountz JD (1998). Reduction of arthritis and pneumonitis in moth-eaten mice by soluble tumor necrosis factor receptor. Arthritis Rheum 41: 139-149.
65. Taher TE, Smit L, Griffioen AW, Schilder-Tol EJ, Borst J, and Pals ST (1996). Signaling through CD44 is mediated by tyrosine kinases: Association with p56lck in T lymphocytes. J Biol Chem 271:2863-2867.
66. Takahashi I, Kiyono H, and Hamada S (1997). CD4+ T-cell population mediates development of inflammatory bowel disease in T-cell receptor alpha chain-deficient mice. Gastroenterology 112:1876-1886.
67. Triantaphyllopoulos K, Croxford J, Baker D, and Chernajovsky Y (1998). Cloning and expression of murine IFN beta and a TNF antagonist for gene therapy of experimental allergic encephalomyelitis. Gene Ther 5:253-263.
68. van Deventer SJ (1997). Tumor necrosis factor and Crohn's disease. Gut 40:443-448.
69. van Hogezand RA and Verspaget HW (1997). New therapies for inflammatory bowel disease: An update on chimeric anti-TNF alpha antibodies and IL-10 therapy. Scand J Gastroenterol Suppl 223:105-107.
70. Van Noort JM and Amor S (1998). Cell biology of autoimmune diseases. Int Rev Cytol 178:127-206.
71. Warren BF and Watkins PE (1994). Animal models of inflammatory bowel disease. J Pathol 172:313-316.
72. Willenbucher RF (1996). Inflammatory bowel disease. Semin Gastrointest Dis 7:94-104.
73. Wittig B, Schwärzler C, Föhr N, Günthert U, and Zöller M (1998). Curative treatment of an experimentally induced colitis by a CD44 variant exon v7 specific antibody. J Immunol 161:1069-1073.
74. Wittig B, Seiter S, Föger N, Schwärzler C, Günthert U, and Zöller M (1997). Functional activity of murine CD44 variant isoforms in allergic and delayed type hypersensitivity. Immunol Lett 57:217-223.
75. Woodside DG, Teague TK, and McIntre BW (1996). Specific inhibition of T lymphocyte coactivation by triggering integrin beta 1 reveals convergence of beta 1, beta 2, and beta 7 signaling pathways. J Immunol 157:700-706.
76. Zheng XX, Steele AW, Hancock WW, Stevens AC, Nickerson PW, Roy-Chaudhury P, Tian Y, and Strom TB (1997). A noncytolytic IL-10/Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD mice. J Immunol 158:4507-4513.
77. Zöller M (1996). Joint features of metastasis formation and lymphocyte maturation and activation. Curr Top Microbiol Immunol 213:215-247.